Publications
Abstracts and Presentations (1104 POSTS)
2023 (68 POSTS)
Evaluating mechanistic underpinnings of environmental chemical effects on feto-maternal interface using a human organ-on-chip model
Moyer H, Kim S, Lam BP, Valdiviezo A, Richardson L, Menon R, Rusyn I, Han A. Evaluating mechanistic underpinnings of environmental chemical effects on feto-maternal interface using a human organ-on-chip model. Lonestar Society of Toxicology Meeting, Houston, TX, December 2023.
Cost-utility analysis of roflumilast cream for plaque psoriasis, including intertriginous, from the Canadian societal perspective
Garrison K, Zhang W, Jensen I, Shah A, Brown S, Stephenson B, Yim C. Cost-utility analysis of roflumilast cream for plaque psoriasis, including intertriginous, from the Canadian societal perspective. Abstract EE303, ISPOR EU 2023.
View AbstractCost consequences of using clevidipine in neurological emergencies from the perspective of a US hospital
Gutierrez M, Wild S, Compton A, Paine E, Jensen I, Shah A. Cost consequences of using clevidipine in neurological emergencies from the perspective of a US hospital. Abstract EE579, ISPOR EU 2023.
View AbstractCost consequences of using clevidipine in cardiac surgery from the perspective of a US hospital
Gutierrez M, Wild S, Compton A, Paine E, Jensen I, Shah A. Cost consequences of using clevidipine in cardiac surgery from the perspective of a US hospital. Abstract EE734, ISPOR EU 2023.
View AbstractCost consequences of using clevidipine in acute hypertension from the perspective of a US hospital
Gutierrez M, Wild S, Compton A, Paine E, Jensen I, Shah A. Cost consequences of using clevidipine in acute hypertension from the perspective of a US hospital. Abstract EE125, ISPOR EU 2023.
View AbstractThe societal costs of metachromatic leukodystrophy (MLD) in the United States
Bean K, Miller B, Jensen I, Howle K, Wilds A, Walz M, et al. The societal costs of metachromatic leukodystrophy (MLD) in the United States. Abstract EE547, ISPOR EU 2023.
View AbstractCost-consequence of cladribine tablets for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in the UK
Miller B, Russel-Szymczyk M, Jensen I, Shah A, Alexopoulos T, Herbert A, et al. Cost-consequence of cladribine tablets for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in the UK. Abstract EE658, ISPOR EU 2023.
View AbstractRadiation exposures from the beneficial use of alumina production residue (red mud)
Rish W, Marschke S, Racz L, Mauro J. Radiation exposures from the beneficial use of alumina production residue (red mud). Poster presented at Society of Environmental Toxicology and Chemistry North America 44th Annual Meeting, Louisville, KY, November 2023.
Assessing sustainable applications of electric arc furnace steel slag as construction aggregate: Applications of probabilistic risk assessment and physiologically-based pharmacokinetic modeling
Racz L, Mittal L, Perry CS, Blanchette A, Proctor D. Assessing sustainable applications of electric arc furnace steel slag as construction aggregate: Applications of probabilistic risk assessment and physiologically-based pharmacokinetic modeling. Poster presented at Society of Environmental Toxicology and Chemistry North America 44th Annual Meeting, Louisville, KY, November 2023.
A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV Plus for the diagnosis of viral respiratory infections from a US health plan perspective
Davies S, Boller E, Beaubrun A, Miller C, Jensen I. A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV Plus for the diagnosis of viral respiratory infections from a US health plan perspective. Abstract ID309. AMP 2023 Annual Meeting & Expo.
View AbstractContinued refinement of systematic review to better facilitate risk assessment needs – Discussion of modifications to evidence synthesis and integration when considering observational data in dose-response assessment
Schaefer H. Continued refinement of systematic review to better facilitate risk assessment needs – Discussion of modifications to evidence synthesis and integration when considering observational data in dose-response assessment. German Federal Institute for Risk Assessment, Virtual, 2023.
Introduction to inhalation exposure modeling
Kramer AJ. Introduction to inhalation exposure modeling. Technical presentation at AIHA Upper Midwest Local Section Professional Development Conference, Roseville, MN, November 2023.
Prevalence of acute uncomplicated cystitis in Japan.
Franklin M, Emden MR, Bauer E, Nguyen AT, Sacks N, Kawamatsu S, Kawano Y, Mitrani-Gold FS, Joshi AV, Ju S, Preib MT. Prevalence of acute uncomplicated cystitis in Japan. Poster presentation, IDWeek, October 2023.
Cost burden of patients with oral antibiotic treatment failure for uncomplicated urinary tract infection in the United States.
Franklin M, Emden MR, Kautz S, Nguyen AT, Sacks NC, Ju S, Mitrani-Gold FS, Joshi AV, Preib MT. Cost burden of patients with oral antibiotic treatment failure for uncomplicated urinary tract infection in the United States. Poster presentation, IDWeek, October 2023.
Evaluating mechanistic underpinnings of environmental chemical effects on feto-maternal interface using a human organ-on-chip model
Moyer HL, Kim S, Lam BP, Valdiviezo A, Richardson L, Menon R, Rusyn I, Han A. Evaluating mechanistic underpinnings of environmental chemical effects on feto-maternal interface using a human organ-on-chip model. Texas A&M University Superfund External Advisory Board Meeting, College Station, TX, October 2023.
Prevention of respiratory syncytial virus hospitalizations (RSVH) in US infants who paid through Medicaid would have a greater benefit for Black, Hispanic, Asian/Pacific Islander, Native American and Other race/ethnicity infants, and have a substantial impact on overall RSVH burden and related costs: Rates of respiratory syncytial virus hospitalization (RSVH) among US infants by race/ethnicity and insurance payer, NIS 2018-2020
Nelson CB, Jiang X, Suh M, Fryzek J. Prevention of respiratory syncytial virus hospitalizations (RSVH) in US infants who paid through Medicaid would have a greater benefit for Black, Hispanic, Asian/Pacific Islander, Native American and Other race/ethnicity infants, and have a substantial impact on overall RSVH burden and related costs: Rates of respiratory syncytial virus hospitalization (RSVH) among US infants by race/ethnicity and insurance payer, NIS 2018-2020. Poster 1536169, IDWeek 2023, Boston, MA, October 2023.
Seasonality of infant respiratory syncytial virus associated bronchiolitis around the US since the onset of COVID-19: Results from four US health systems 2016-17 through 2022-23
Blatt A, Suh M, Walter E, Jr., Wood CT, Espinosa C, Enriquez-Bruce ME…Movva N, Reichert H, Fryzek JP, et al. Seasonality of infant respiratory syncytial virus associated bronchiolitis around the US since the onset of COVID-19: Results from four US health systems 2016-17 through 2022-23. Poster 1535431, IDWeek 2023, Boston, MA, October 2023.
Overview of global real-world data sources for pediatric pharmacoepidemiologic research
Wharton GT, Becker C, Bennett D, Burcu M, Bushnell G, Ferrajolo C, Kaplan S, McMahon AW, Movva N, Raman SR, Scholle O, Suh M, Sun JW, Horton DB. Overview of global real-world data sources for pediatric pharmacoepidemiologic research. Poster presentation at the 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Halifax, Nova Scotia, August 2023 [ISPE Journal].
View AbstractPhysiologically-based pharmacokinetic model to predict HFC-134a in exhaled breath following albuterol inhaler use.
Covington TR, Sterner TR. Physiologically-based pharmacokinetic model to predict HFC-134a in exhaled breath following albuterol inhaler use. Poster presented at the 2023 Toxicology and Risk Assessment Conference, Miamisburg, OH, August 25, 2023.
Evaluating mechanistic underpinnings of environmental chemical effects on feto-maternal interface using a human organ-on-chip model
Moyer HL, Kim S, Lam BP, Valdiviezo A, Richardson L, Menon R, Rusyn I, Han A. Evaluating mechanistic underpinnings of environmental chemical effects on feto-maternal interface using a human organ-on-chip model. Texas A&M University Toxicology Annual Retreat, College Station, TX, August 2023.